Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesNeutriSci International Inc

NeutriSci International Inc

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
None CAD 0.00(0%)
Last update at 2026-11-04T21:00:15.065199Z
Market Cap
0.89M

Momentum Score

…

NeutriSci International Inc. develops and markets nutraceutical products in Canada, Germany, and Japan. It offers neuenergy, an energy tab designed to deliver enhanced focus and mental clarity. The company sells its products through a distribution network of retail storefront and online markets. NeutriSci International Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
11.46
Low
18.98
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on NeutriSci International Inc is limited; it appears positioned as an early-stage developer of nutritional and health-related products focused on research, product development and commercialization. Long-term growth may be driven by successful product development, regulatory clearances, strategic partnerships and licensing that could support market expansion, and investors may find exposure to the nutraceutical sector and milestone-driven upside of interest.

The primary investment risks include execution and financing risk typical of small, early-stage issuers, together with regulatory approval uncertainty, competitive pressures and limited market liquidity.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
11.61
Dividend Yield
-
Revenue TTM
0.06M
Revenue Per Share
-
Gross Profit TTM
-0.10M
Debt / Equity
-
ROE
-611.39%
Net Debt
0.00M
ROCE
90.60%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -0.55M -0.77M -1.57M -1.95M -1.61M
Net income -0.55M -0.77M -1.57M -1.95M -1.61M
Selling general administrative 0.44M 0.60M 1.25M 1.71M 1.42M
Selling and marketing expenses - 0.00M 0.07M 0.21M 0.23M
Gross profit -0.03M -0.04M -0.02M -0.01M 0.00M
Reconciled depreciation 0.03M 0.04M 0.05M 0.03M 0.01M
Ebit - -0.69M -1.36M -1.94M -1.65M
Ebitda - -0.65M -1.32M -1.92M -1.65M
Depreciation and amortization - 0.04M 0.05M 0.03M 0.01M
Operating income -0.50M -0.69M -1.36M -1.94M -1.65M
Other operating expenses - 1.15M 1.47M 2.02M 1.75M
Interest expense 0.00M 0.00M 0.00M 0.00M 0.00M
Net interest income -0.00M -0.00M -0.00M -0.00M -0.00M
Income tax expense - - 0.03M 0.00M 0.00M
Total revenue 0.06M 0.46M 0.08M 0.07M 0.10M
Total operating expenses 0.56M 0.65M 1.37M 1.94M 1.65M
Cost of revenue 0.09M 0.50M 0.10M 0.08M 0.09M
Total other income expense net -0.05M -0.08M -0.18M -0.01M 0.04M
Net income from continuing ops -0.55M -0.77M -1.57M -1.95M -1.61M
Net income applicable to common shares - -0.77M -0.77M -1.95M -1.61M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 0.33M 0.82M 0.53M 0.50M 0.55M
Total liab 0.95M 0.87M 0.62M 0.66M 0.28M
Total stockholder equity -0.62M -0.05M -0.09M -0.16M 0.28M
Other current liab 0.04M 0.27M 0.07M 0.07M 0.03M
Common stock 31.03M - 29.62M 28.14M 27.30M
Capital stock 31.03M 30.89M 29.62M 28.14M 27.30M
Retained earnings -36.47M -35.70M -34.13M -32.18M -30.56M
Cash 0.18M 0.03M 0.01M 0.00M 0.28M
Total current liabilities 0.89M 0.81M 0.62M 0.66M 0.28M
Net debt 0.00M 0.03M - 0.05M -
Short long term debt 0.12M - - 0.05M -
Other stockholder equity 0.30M - 0.45M 0.32M 0.27M
Property plant equipment 0.13M - 0.21M 0.02M 0.02M
Total current assets 0.20M 0.65M 0.31M 0.49M 0.53M
Net tangible assets -0.62M - -0.09M -0.16M 0.28M
Net receivables 0.01M - 0.01M 0.02M 0.08M
Long term debt 0.06M 0.06M - - -
Inventory 0.01M 0.49M 0.27M 0.34M 0.12M
Accounts payable 0.73M 0.44M 0.52M 0.48M 0.24M
Non currrent assets other - - - 0.02M 0.02M
Non current assets total 0.13M 0.17M 0.21M 0.02M 0.02M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments 0.00M -0.00M -0.11M -0.11M -0.01M
Change to liabilities - -0.03M 0.00M -0.11M 0.35M
Total cashflows from investing activities - -0.00M -0.00M -0.11M -0.11M
Net borrowings - 0.12M 0.12M -0.05M 0.04M
Total cash from financing activities 0.26M 0.32M 1.17M 1.64M 0.97M
Change to operating activities - 0.11M 0.11M 0.10M -0.06M
Net income -0.55M -0.77M -1.57M -1.95M -1.61M
Change in cash -0.01M 0.14M 0.02M 0.01M -0.27M
Begin period cash flow 0.01M 0.03M 0.01M 0.00M 0.28M
End period cash flow 0.00M 0.18M 0.03M 0.01M 0.00M
Total cash from operating activities -0.26M -0.17M -1.04M -1.52M -1.24M
Issuance of capital stock - 0.20M 0.40M 1.55M 0.93M
Depreciation 0.03M 0.04M 0.05M 0.03M 0.01M
Change to inventory 0.04M 0.42M -0.34M 0.07M -0.23M
Change to account receivables -0.00M -0.00M 0.00M 0.01M 0.00M
Other cashflows from financing activities - 0.24M 0.85M 0.13M 0.08M
Change to netincome - 0.06M 0.06M 0.33M 0.30M
Capital expenditures 0.00M 0.00M 0.11M 0.11M 0.11M
Change in working capital 0.21M 0.50M -0.11M 0.07M 0.07M
Stock based compensation 0.00M 0.00M 0.50M 0.33M 0.26M
Other non cash items - 0.06M 0.09M 0.00M 0.00M
Free cash flow -0.26M -0.17M -1.15M -1.63M -1.24M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
RX
Biosyent Inc.		 0.30
1.78%		 17.15 19.10 15.85 3.96 4.11 3.31 11.03
DB
Decibel Cannabis Company Inc		 0.21
11.67%		 2.01 - 8.67 0.67 1.20 0.99 17.75
ZYUS
ZYUS Life Sciences Corporation		 0.03
9.38%		 0.35 - - 108.48 4.41 140.29 -4.26
LSL
LSL Pharma Group Inc.		 0.01
1.64%		 0.31 20.75 - 1.88 1.89 2.85 10.19

Profile*

NeutriSci International Inc

NeutriSci International Inc. develops and markets nutraceutical products in Canada, Germany, and Japan. It offers neuenergy, an energy tab designed to deliver enhanced focus and mental clarity. The company sells its products through a distribution network of retail storefront and online markets. NeutriSci International Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

1600 ? 609 Granville Street, Vancouver, BC, Canada, V7Y 1C3

403 264 6320

https://www.neutrisci.com

Name Title Year Born
Mr. William C. Adams IV VP and Trustee 1956
Mr. Thomas C. Spalding Jr., CFA Portfolio Mang. 1962
Mr. Daniel S. Solender Portfolio Mang. 1967
Mr. Johnathan N. Wilhelm J.D. Portfolio Mang. NA
Mr. Glen Rehman CEO, President & Director NA
Mr. John Robert Chisholm Chief Financial Officer 1962
Ms. Jaycee Waters Operations & Logistics Manager NA
Mr. Thierry Sorhaitz Vice President of Sales & Marketing NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 30.50
+15.05%
DSV
CAD 11.02
+14.55%
USA
CAD 4.29
+13.19%
NUAG
CAD 7.70
+12.90%
GMIN
CAD 43.79
+12.86%
DRUG
CAD 26.11
-29.58%
HUT
CAD 68.98
-22.41%
UCU
CAD 2.09
-14.34%
VET
CAD 14.87
-14.29%
PHX
CAD 10.96
-13.56%

Equity Sectors*

  • Basic Materials

    +5.46%

  • Communication Services

    +3.38%

  • Consumer Cyclical

    +3.11%

  • Consumer Defensive

    +1.35%

  • Energy

    -4.79%

  • Financial Services

    +2.66%

  • Healthcare

    -0.72%

  • Industrials

    -0.11%

  • Real Estate

    +1.84%

  • Technology

    +1.05%

  • Utilities

    +0.39%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…